Literature DB >> 31096291

[Prescription and Utilization of Sports Therapy Programs following Cardiac Rehabilitation 2006-2013].

Lars Gabrys1, Christian Schmidt2.   

Abstract

PURPOSE: Physical exercise interventions are well accepted and widely used in cardiac rehabilitation programs. To ensure long-lasting effects on physical fitness and the maintenance of work ability a subsequent transfer to rehabilitation sport programs following cardiac rehabilitation is intended in a timely manner. The aim of the present study is to evaluate prescription and utilization rates of rehabilitation sport programs following cardiac rehabilitation.
METHODS: The present paper analyzes referral rates and the actual utilization of those programs in patients who had a cardiac rehabilitation in the years 2006-2013 using insurance data of the German pension fund.
RESULTS: Overall, reductions in the prescription of rehabilitation sport programs can be observed. In 2013 55.7% (m) and 62.6% (w) of patients received a prescription for rehabilitation sport programs following cardiac rehabilitation. In contrast to declining prescription rates from 64.2 to 55.7% (m) and 68.0 to 62.6% (w) an increase in sports participation between 3-7% can be observed.
CONCLUSION: Overall, participation rates between 9.7% and 22.5% (2012) seem not sufficient to promote long-term physical activity behavior change. Next to our evaluation, determinants and barriers for program participation should be investigated. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31096291     DOI: 10.1055/a-0869-9810

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  1 in total

1.  Exercise-Based Cardiac Rehabilitation: Secondary Data Analyses of Mortality and Working Capacity in Germany, 2010-2017.

Authors:  Lars Gabrys; Johannes Soff; Christian Thiel; Christian Schmidt; Enno Swart; Dirk Peschke
Journal:  Sports Med Open       Date:  2021-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.